Table of Contents
Volume 6 | Issue 4
Publication Date: January 2005- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
203-204 |
Implications of the Iressa® Survival Evaluation in Lung Cancer Trial and the Future of Gefitinib Chandra P. Belani, Sakkaraiappan Ramalingam |
|
Meeting Highlights | ||
209-213 |
Highlights From: 29th European Society of Medical Oncology Congress, Vienna, Austria G. Kesava Reddy, Nancy Price, Chandra P. Belani |
|
Research in Brief | ||
214-216 |
Clinical Development of Gefitinib in Non–Small-Cell Lung Cancer and the Iressa® Survival Evaluation in Lung Cancer Trial Nancy Price, Chandra P. Belani |
|
Comprehensive Review | ||
217-224 |
The Prospect of Biologic Staging of Non–Small-Cell Lung Cancer Peyman Sardari Nia, Eric Van Marck, Paul Van Schil |
|
Commentary | ||
225-226 |
Biologic Staging of Non–Small-Cell Lung Cancer: Prospect or Proposal? Fabrice Barlési, William Jacot, Jean-Louis Pujol |
|
Comprehensive Reviews | ||
227-236 |
Replacement and Suicide Gene Therapy for Targeted Treatment of Lung Cancer Thomas T. Poulsen, Nina Pedersen, Hans S. Poulsen |
|
237-244 |
Nonclassical Retinoids and Lung Carcinogenesis Konstantin H. Dragnev, W. Jeffrey Petty, Yan Ma, James R. Rigas, Ethan Dmitrovsky |
|
Original Contributions | ||
245-249 |
Results of a Phase II Trial of Gemcitabine in Patients with Non–Small-Cell Lung Cancer and a Performance Status of 2 Marcus A. Neubauer, Craig H. Reynolds, Marcos G. Joppert, Thomas Whittaker, Habib Ghaddar, Thomas A. Marsland, Lina Asmar |
|
250-254 |
FANCD2 Expression in Advanced Non–Small-Cell Lung Cancer and Response to Platinum-Based Chemotherapy Miriam Ferrer, Simone W. Span, Barbara Vischioni, Joost J. Oudejans, Paul J. van Diest, Johan P. de Winter, Giuseppe Giaccone, Frank A.E. Kruyt |
|